View More Recent Stories

Nov 5, 2024 06:28AM Tempus AI Inc (TEM) PT Raised to $56 at Needham

Nov 4, 2024 04:01PM Tempus AI (TEM) to Acquire Ambry Genetics, Reports Q3

Oct 21, 2024 07:01AM Avacta and Tempus (TEM) Enter Strategic Collaboration to Advance AI-Driven Drug Development in Oncology

Oct 15, 2024 07:21AM Tempus AI Inc (TEM) PT Raised to $57 at Loop Capital

Sep 4, 2024 08:32AM Tempus AI (TEM) Announces Real World Data Collaboration with BioNTech (BNTX)

Aug 16, 2024 08:31AM Personalis, Inc. (PSNL) and Tempus (TEM) Expand Collaboration

Aug 12, 2024 03:50AM Piper Sandler Starts Tempus AI Inc (TEM) at Neutral

Aug 7, 2024 05:02AM Tempus AI, Inc (TEM) Reports Q2 Loss of $6.86; offers guidance

Jul 9, 2024 09:33AM BofA Securities Starts Tempus AI Inc (TEM) at Buy

Jul 9, 2024 08:55AM Wall Street starts Tempus AI coverage after IPO, shares climb

Jul 9, 2024 07:14AM Loop Capital Starts Tempus AI Inc (TEM) at Buy

Jul 9, 2024 07:09AM William Blair Starts Tempus AI Inc (TEM) at Outperform

Jul 9, 2024 05:54AM Needham Starts Tempus AI Inc (TEM) at Buy

Jul 9, 2024 05:54AM TD Cowen Starts Tempus AI Inc (TEM) at Buy, 'largest oncology Dx co.'

Jul 9, 2024 04:35AM Morgan Stanley Starts Tempus AI Inc (TEM) at Overweight

Jul 9, 2024 03:53AM JPMorgan Starts Tempus AI Inc (TEM) at Overweight

Jul 9, 2024 03:22AM Stifel Starts Tempus AI Inc (TEM) at Buy

Jun 26, 2024 09:30AM Tempus AI (TEM) Receives U.S. FDA 510(k) Clearance for Tempus ECG-AF

Jun 17, 2024 05:42AM Tempus AI (TEM) Prices 11.1M Share IPO at $37/sh

Jun 14, 2024 11:50AM Tempus AI (TEM) IPO Opens Higher by 8%

Jun 14, 2024 10:22AM Tempus AI (TEM) Indicated At $47, IPO Priced At $37

View More Recent Stories